A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...

Key TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new ...

Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of ...

In the INDI-UTI study, eligible children were between 3 months and 12 years of age, were febrile (≥38°C) at the time of or within 24 hours preceding the start of treatment, and had growth of ...

A virulent strain of antibiotic-resistant superbug that causes severe disease has been found circulating in a Malaysian ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...

Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...